SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-16-017692
Filing Date
2016-10-24
Accepted
2016-10-24 17:15:28
Documents
33
Period of Report
2016-08-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0816_nexusbiopharma.htm 10-Q 353081
2 CERTIFICATION f10q0816ex31i_nexusbiopharma.htm EX-31.1 16228
3 CERTIFICATION f10q0816ex32i_nexusbiopharma.htm EX-32.1 4316
  Complete submission text file 0001213900-16-017692.txt   1378542

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE nexs-20160831.xml EX-101.INS 124544
5 XBRL SCHEMA FILE nexs-20160831.xsd EX-101.SCH 21776
6 XBRL CALCULATION FILE nexs-20160831_cal.xml EX-101.CAL 16543
7 XBRL DEFINITION FILE nexs-20160831_def.xml EX-101.DEF 51823
8 XBRL LABEL FILE nexs-20160831_lab.xml EX-101.LAB 165725
9 XBRL PRESENTATION FILE nexs-20160831_pre.xml EX-101.PRE 112718
Mailing Address 8 HILLSIDE AVE STE 108 MONTCLAIR NJ 07042
Business Address 8 HILLSIDE AVE STE 108 MONTCLAIR NJ 07042 832-758-7488
NEXUS BIOPHARMA INC (Filer) CIK: 0001424151 (see all company filings)

IRS No.: 753267338 | Fiscal Year End: 0228
Type: 10-Q | Act: 34 | File No.: 000-53207 | Film No.: 161948744
SIC: 2834 Pharmaceutical Preparations